• NCBIO Annual Meeting 2019

    • Share:
    •  
    Name: NCBIO Annual Meeting 2019
    Date: October 3, 2019
    Time: 8:00 AM - 3:00 PM EDT
    Registration: Register Now
    Event Description:
    Preliminary agenda noted below. The program also features a Networking Break and Lunch, and NCBIO Business Session. 

    TWO KEYNOTES:

    New Innovations: Personalized Health and Cancer Treatment  
    Industry leader describes why these innovations have developed now, discusses the promise of the therapies, and highlights pricing and value.  
    • Marty Murphy, Ph.D., Founder and Former Chief Executive Officer, Hipple Cancer Research Center; Co-founder, Society for Translational Oncology; Founding Chairman & Chief Executive Officer, AlphaMed Consulting 
    Financial Market
    This keynote discusses best strategies to raise funding, the impact of current regulations on product pricing, and the ability of companies to continue to innovate. Take a deep dive into the economics of the life science space and the economic cross currents that industry is navigating. 
    • Peter Meath, Managing Director, Co-Head of Healthcare & Life Sciences, Commercial Banking, J.P. Morgan
    • Lauren Ruane, Managing Director, Equity Capital Markets, J.P. Morgan
    TWO PANELS:
    Access and Availability 
    This interactive session features a discussion of policies necessary to make both novel and established therapies accessible to patients. Learn more about the realities and responsive policies that are maturing or effecting patient access including value-based reimbursement, pharmaceutical rebate reform, and other important topics.
    • Dora Hughes, M.D., M.P.H., Associate Research Professor, Department of Health Policy and Management, Milken Institute School of Public Health, George Washington University
    • Robin Levy, Senior Director, Public Policy and Advocacy, International Myeloma Foundation
    • Marianne Lopez, Ph.D., M.P.H. Research Director, Value-Based Payment Reform, Duke-Margolis Center for Health Policy (Moderator)
    • Vadim Lubarsky, Executive Director, CMS Policy and Reimbursement, Novartis
    • Reginald Munden M.D., Interim Vice President Clinical Operations and Cancer Services, Wake Forest Baptist Health
    • Representative from Insurance Provider
    Ag and Human Microbiome 
    This discussion will take us from acknowledging the microbiome to understanding how to manipulate it for nutritional and therapeutic purposes.
    • Anne Ballou, Research and Development Scientist, Premex
    • Nick Gillitt, Ph.D., Chief Science Officer, David H Murdock Research Institute
    • Jared Jensen, Nematologist and Project Leader, AgBiome
    • John Ryals, Ph.D., Former President and Chief Executive Officer, Metabolon; Chair Emeritus, Board of Directors, Metabolon; Board of Directors, AgBiome (Moderator)

    Thank you to our sponsors.
    Platinum:
    BIO, Bioventus, Cook Medical, and VWR
    Gold: BDO and FUJIFILM Diosynth Biotechnologies
    Silver: Charter Medical, Office Depot, The Conafay Group, UCB

    Bronze: Business Wire, G1 Therapeutics and Novozymes

    If you are interested in sponsoring the Annual Meeting, contact Laura Gunter for details.
    Location:
    NC Biotechnology Center
    15 TW Alexander Drive
    RTP, NC 27709

    The NC Biotechnology Center partners with two nearby hotels, both providing free shuttle service to/from the Center.
    Date/Time Information:
    October 3
    8:00 a.m. - 3:00 p.m.
    Contact Information:
    Amber Niebauer, Events Director, NCBIO
    Fees/Admission:
    No cost for NCBIO members.
    Set a Reminder:
    Enter your email address below to receive a reminder message.